Bridge to Life and Tevosol merge to commercialize organ preservation technology

Bridge to Life, a supplier of organ preservation solutions, and Tevosol, a medical device startup, announced their merger to develop and commercialize Tevosol's portable ex-vivo lung perfusion machine and normothermic organ preservation platform. The merger was announced on February 9, 2021.

“Together we can fulfill the great promise of this emerging clinical practice—and we're already working on exciting projects beyond lung transplantation and a host of other possibilities for the future.”prnewswire.com

• 1 source
• prnewswire.comBridge to Life and Tevosol Merge to Commercialize Portable Normothermic Machine Preservation Technology Platform for Organ TransplantationBridge to LifeFeb 9, 2021

Summarized from public sources; check the original articles before acting on it.